The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rizzo, L. V.
Right arrow Articles by Caspi, R. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rizzo, L. V.
Right arrow Articles by Caspi, R. R.
Right arrowPubmed/NCBI databases
*Substance via MeSH

The Journal of Immunology, Vol 156, Issue 4 1654-1660, Copyright © 1996 by American Association of Immunologists

ARTICLES

Establishment and characterization of a murine CD4+ T cell line and clone that induce experimental autoimmune uveoretinitis in B10.A mice

LV Rizzo, P Silver, B Wiggert, F Hakim, RT Gazzinelli, CC Chan and RR Caspi
Laboratory of Immunology, NEI/NIH, Bethesda, MD 20892-1858, USA.

B10.A mice develop experimental autoimmune uveoretinitis after active immunization with the interphotoreceptor retinoid-binding protein (IRBP). CD4+ T cells play an important role in the development of the disease. In this study we have isolated and characterized a CD4+ T cell line and a T cell clone that induce experimental autoimmune uveoretinitis when transferred into naive B10.A mice. The cell line was isolated from draining lymph nodes of IRBP-immunized animals by repeated cycles of IRBP stimulation. The line was shown to be pathogenic after 4 rounds of in vitro stimulation with IRBP at 5 x 10(6) cells/mouse. A T cell clone derived from this line by limiting dilution was shown to be pathogenic when the same number of cells was injected; incidence and severity of disease, however, were much lower. After 16 rounds of IRBP-specific stimulation the cell line was pathogenic at 10(5) cells/mouse. Analysis of the V beta repertoire revealed that at this point the line was mostly composed of V beta 8.2- and V beta 6-positive cells (> 80% of the population). The uveitogenic clone expressed V beta 8.2. Both the T cell line and the clone elaborated an unrestricted lymphokine profile in vitro. However, when these cells were adoptively transferred into naive recipients, mRNA isolated from the uveitic retina showed only Th1 type cytokines. These data help to characterize the nature of pathogenic cells involved in ocular autoimmunity.


This article has been cited by other articles:


Home page
 J. Leukoc. Biol.Home page
L. M. Cortes, D. Avichezer, P. B. Silver, D. Luger, M. J. Mattapallil, C.-C. Chan, and R. R. Caspi
Inhibitory peptide analogs derived from a major uveitogenic epitope protect from antiretinal autoimmunity by inducing type 2 and regulatory T cells
J. Leukoc. Biol., August 1, 2008; 84(2): 577 - 585.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
X. Liu, Y. S. Lee, C.-R. Yu, and C. E. Egwuagu
Loss of STAT3 in CD4+ T Cells Prevents Development of Experimental Autoimmune Diseases
J. Immunol., May 1, 2008; 180(9): 6070 - 6076.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
D. Luger, P. B. Silver, J. Tang, D. Cua, Z. Chen, Y. Iwakura, E. P. Bowman, N. M. Sgambellone, C.-C. Chan, and R. R. Caspi
Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category
J. Exp. Med., April 14, 2008; 205(4): 799 - 810.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
M. Wang, F. Bai, M. Pries, S. Buus, J. U. Prause, and M. H. Nissen
Identification of MHC class I h-2 kb/db-restricted immunogenic peptides derived from retinal proteins.
Invest. Ophthalmol. Vis. Sci., September 1, 2006; 47(9): 3939 - 3945.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
H. Kitamei, K. Iwabuchi, K. Namba, K. Yoshida, Y. Yanagawa, N. Kitaichi, M. Kitamura, S. Ohno, and K. Onoe
Amelioration of experimental autoimmune uveoretinitis (EAU) with an inhibitor of nuclear factor-{kappa}B (NF-{kappa}B), pyrrolidine dithiocarbamate
J. Leukoc. Biol., June 1, 2006; 79(6): 1193 - 1201.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
H. Shao, Y. Peng, T. Liao, M. Wang, M. Song, H. J. Kaplan, and D. Sun
A Shared Epitope of the Interphotoreceptor Retinoid-Binding Protein Recognized by the CD4+ and CD8+ Autoreactive T Cells
J. Immunol., August 1, 2005; 175(3): 1851 - 1857.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
L. M. Bagenstose, R. K. Agarwal, P. B. Silver, D. M. Harlan, S. C. Hoffmann, R. L. Kampen, C.-C. Chan, and R. R. Caspi
Disruption of CD40/CD40-Ligand Interactions in a Retinal Autoimmunity Model Results in Protection without Tolerance
J. Immunol., July 1, 2005; 175(1): 124 - 130.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
A. P. Martin, L. V. de Moraes, C. E. Tadokoro, A. G. Commodaro, E. Urrets-Zavalia, G. A. Rabinovich, J. Urrets-Zavalia, L. V. Rizzo, and H. M. Serra
Administration of a Peptide Inhibitor of {alpha}4-Integrin Inhibits the Development of Experimental Autoimmune Uveitis
Invest. Ophthalmol. Vis. Sci., June 1, 2005; 46(6): 2056 - 2063.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
H. Shao, S. L. Sun, H. J. Kaplan, and D. Sun
Characterization of Rat CD8+ Uveitogenic T Cells Specific for Interphotoreceptor Retinal-Binding Protein 1177-1191
J. Immunol., August 15, 2004; 173(4): 2849 - 2854.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
M. Takeuchi, H. Keino, T. Kezuka, M. Usui, and O. Taguchi
Immune Responses to Retinal Self-Antigens in CD25+CD4+ Regulatory T-Cell-Depleted Mice
Invest. Ophthalmol. Vis. Sci., June 1, 2004; 45(6): 1879 - 1886.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
A. Honda, A. Ametani, T. Matsumoto, A. Iwaya, H. Kano, S. Hachimura, K. Ohkawa, S. Kaminogawa, K. Suzuki, E. E. Sercarz, et al.
Vaccination with an immunodominant peptide of bovine type II collagen induces an anti-TCR response, and modulates the onset and severity of collagen-induced arthritis
Int. Immunol., May 1, 2004; 16(5): 737 - 745.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
H. Xu, P. B. Silver, T. K. Tarrant, C.-C. Chan, and R. R. Caspi
TGF-{beta} Inhibits Activation and Uveitogenicity of Primary but Not of Fully Polarized Retinal Antigen-Specific Memory-Effector T Cells
Invest. Ophthalmol. Vis. Sci., November 1, 2003; 44(11): 4805 - 4812.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
K.-H. Sonoda, Y. Sasa, H. Qiao, C. Tsutsumi, T. Hisatomi, S. Komiyama, T. Kubota, T. Sakamoto, Y.-I. Kawano, and T. Ishibashi
Immunoregulatory Role of Ocular Macrophages: The Macrophages Produce RANTES to Suppress Experimental Autoimmune Uveitis
J. Immunol., September 1, 2003; 171(5): 2652 - 2659.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. L. Wahlsten, H. L. Gitchell, C.-C. Chan, B. Wiggert, and R. R. Caspi
Fas and Fas Ligand Expressed on Cells of the Immune System, not on the Target Tissue, Control Induction of Experimental Autoimmune Uveitis
J. Immunol., November 15, 2000; 165(10): 5480 - 5486.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
P. B. Silver, K. S. Hathcock, C.-C. Chan, B. Wiggert, and R. R. Caspi
Blockade of Costimulation Through B7/CD28 Inhibits Experimental Autoimmune Uveoretinitis, But Does Not Induce Long-Term Tolerance
J. Immunol., November 1, 2000; 165(9): 5041 - 5047.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
H.-R. Jiang, L. Lumsden, and J. V. Forrester
Macrophages and Dendritic Cells in IRBP-Induced Experimental Autoimmune Uveoretinitis in B10RIII Mice
Invest. Ophthalmol. Vis. Sci., December 1, 1999; 40(13): 3177 - 3185.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
D. S. Gregerson, J. W. Torseth, S. W. McPherson, J. P. Roberts, T. Shinohara, and D. J. Zack
Retinal Expression of a Neo-Self Antigen, {beta}-Galactosidase, Is Not Tolerogenic and Creates a Target for Autoimmune Uveoretinitis
J. Immunol., July 15, 1999; 163(2): 1073 - 1080.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
R. K. Agarwal, C.-C. Chan, B. Wiggert, and R. R. Caspi
Pregnancy Ameliorates Induction and Expression of Experimental Autoimmune Uveitis
J. Immunol., March 1, 1999; 162(5): 2648 - 2654.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
T. K. Tarrant, P. B. Silver, J. L. Wahlsten, L. V. Rizzo, C.-C. Chan, B. Wiggert, and R. R. Caspi
Interleukin 12 Protects from a T Helper Type 1-mediated Autoimmune Disease, Experimental Autoimmune Uveitis, through a Mechanism Involving Interferon gamma , Nitric Oxide, and Apoptosis
J. Exp. Med., January 18, 1999; 189(2): 219 - 230.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
T. K. Tarrant, P. B. Silver, C.-C. Chan, B. Wiggert, and R. R. Caspi
Endogenous IL-12 Is Required for Induction and Expression of Experimental Autoimmune Uveitis
J. Immunol., July 1, 1998; 161(1): 122 - 127.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
V. Kumar, F. Aziz, E. Sercarz, and A. Miller
Regulatory T Cells Specific for the Same Framework 3 Region of the Vbeta 8.2 Chain Are Involved in the Control of Collagen II-induced Arthritis and Experimental Autoimmune Encephalomyelitis
J. Exp. Med., May 19, 1997; 185(10): 1725 - 1733.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1996 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1996 by The American Association of Immunologists, Inc. All rights reserved.